111![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RHINOCORT AQUA® Nasal Spray safely and effectively. See full prescribing information for RHINOCORT AQUA Nasal Spray HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RHINOCORT AQUA® Nasal Spray safely and effectively. See full prescribing information for RHINOCORT AQUA Nasal Spray](https://www.pdfsearch.io/img/cff0a23ca4c0e36e910671e8b43e4821.jpg) | Add to Reading ListSource URL: www1.astrazeneca-us.comLanguage: English - Date: 2011-01-11 09:45:59
|
---|
112![STEP THERAPY POLICY Nasal Steroids Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Beconase AQ® (beclomethasone nasal spray – GlaxoSmithKline) STEP THERAPY POLICY Nasal Steroids Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Beconase AQ® (beclomethasone nasal spray – GlaxoSmithKline)](https://www.pdfsearch.io/img/ccf87bb7ec0b9f7bc8595f8b33e4ffec.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-09-02 09:27:20
|
---|
113![Migranal® (dihydroergotamine mesylate, USP) Nasal Spray The solution used in Migranal® (dihydroergotamine mesylate, USP) Nasal Spray (4 mg/mL) is Migranal® (dihydroergotamine mesylate, USP) Nasal Spray The solution used in Migranal® (dihydroergotamine mesylate, USP) Nasal Spray (4 mg/mL) is](https://www.pdfsearch.io/img/8535800502f262b35ef560612e18e38c.jpg) | Add to Reading ListSource URL: www.migranal.comLanguage: English - Date: 2014-06-27 14:18:08
|
---|
114![BPCA CLINICAL SUMMARY OF NDA[removed], SE8-028 APPLICATION: APPLICANT: MEDICAL OFFICER: TEAM LEADER: BPCA CLINICAL SUMMARY OF NDA[removed], SE8-028 APPLICATION: APPLICANT: MEDICAL OFFICER: TEAM LEADER:](https://www.pdfsearch.io/img/40440aa4b3778c8034039fdb9775f72a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-09-14 08:01:31
|
---|
115![Summary Basis of Decision Avamys Summary Basis of Decision Avamys](https://www.pdfsearch.io/img/dc4c8ac16b184f5b129cdcad6e8be0bc.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:26:37
|
---|
116![Pharmaceutical sciences / Drugs / Employment compensation / Drug safety / Over-the-counter drug / Flexible spending account / Pharmaceutical drug / Nasal spray / Antipruritic / Medicine / Pharmacology / Pharmaceuticals policy Pharmaceutical sciences / Drugs / Employment compensation / Drug safety / Over-the-counter drug / Flexible spending account / Pharmaceutical drug / Nasal spray / Antipruritic / Medicine / Pharmacology / Pharmaceuticals policy](/pdf-icon.png) | Add to Reading ListSource URL: www.osc.ct.govLanguage: English - Date: 2011-10-31 14:29:22
|
---|
117![Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Nonprescription Drugs Advisory Committee Meeting July 31, 2013 Location: The DoubleTree by Hilton Hotel Washington DC/Silver Spr Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Nonprescription Drugs Advisory Committee Meeting July 31, 2013 Location: The DoubleTree by Hilton Hotel Washington DC/Silver Spr](https://www.pdfsearch.io/img/99cf6de5e31aea01597193f095c605e9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
118![Medication Guide Medication Guide Lazanda® (La-ZAN-da) CII (fentanyl) nasal spray 100 mcg, 400 mcg Medication Guide Medication Guide Lazanda® (La-ZAN-da) CII (fentanyl) nasal spray 100 mcg, 400 mcg](https://www.pdfsearch.io/img/61d0944de500759e32544971bb10e78d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
119![flonase nasal spray, 50 mcg flonase nasal spray, 50 mcg](https://www.pdfsearch.io/img/e3e1a43b9644557abaa0d19cd0fdc1d6.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-09-14 08:01:31
|
---|
120![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASTEPRO® Nasal Spray safely and effectively. See full prescribing information for ASTEPRO Nasal Spray. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASTEPRO® Nasal Spray safely and effectively. See full prescribing information for ASTEPRO Nasal Spray.](https://www.pdfsearch.io/img/6dd79fd36e8c6f990aba872334a78284.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-09-21 16:08:17
|
---|